Lv4
708 积分 2024-08-20 加入
Isolation and characterization of charge variants of infliximab biosimilar HS626
3个月前
已完结
Acceptable changes in quality attributes of glycosylated biopharmaceuticals
3个月前
已完结
Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis
5个月前
已完结
In-Depth Structure and Function Characterization of Heterogeneous Interchain Cysteine-Conjugated Antibody–Drug Conjugates
6个月前
已完结
Synthesis and Evaluation of Hydrophilic Linkers for Antibody–Maytansinoid Conjugates
7个月前
已完结
Strategies and challenges for the next generation of antibody–drug conjugates
7个月前
已完结
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
7个月前
已完结
Advances in the assessment and control of the effector functions of therapeutic antibodies
7个月前
已完结
Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
7个月前
已完结
Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn Differentially with Pharmacokinetic Consequences
7个月前
已完结
皖公网安备34019202002308
